{
    "Systemic Therapy for Advanced or Metastatic Disease": {
        "ALK Rearrangement Positive": {
            "Alectinib": "Progression (See NSCL-22)",
            "Brigatinib": "Progression (See NSCL-22)",
            "Lorlatinib": "Progression (See NSCL-22)",
            "Ceritinib": "Progression (See NSCL-22)",
            "Crizotinib": "Progression (See NSCL-22)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}